Previous close | 1.3000 |
Open | 1.3000 |
Bid | 1.6000 |
Ask | 1.9500 |
Strike | 35.00 |
Expiry date | 2024-11-15 |
Day's range | 1.3000 - 1.3000 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Review Qiagen's (QGEN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data // New software advances precision medicine by enabling smaller and decentralized labs to adopt NGS testing with efficiency, consistency and confidence // Combination of QCI Secondary Analysis and QCI Interpret provide a secure and compliant environment for trusted and scalable bioinformatics workflows for oncology and inher
It's been a good week for Qiagen N.V. ( NYSE:QGEN ) shareholders, because the company has just released its latest...